Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congestive heart failure.

C W Yancy1, B G Firth

  • 1University of Texas Southwestern Medical Center, Dallas.

Disease-A-Month : DM
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Congestive heart failure (CHF) affects 4 million Americans, impacting every organ system. Understanding its pathophysiology is key to developing new treatments and preventative strategies for this serious condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart transplantation outcomes in cardiac sarcoidosis.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2021
Same author

History of cigarette smoking and heart transplant outcomes.

International journal of cardiology. Heart & vasculature·2020
Same author

Increased incidence and mortality associated with skin cancers after cardiac transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

Congestive heart failure (Greenwich, Conn.)·2002
Same author

Outcomes after emergency department discharge with a primary diagnosis of heart failure.

American heart journal·2001
Same author

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

The New England journal of medicine·2001
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Congestive heart failure (CHF) is a complex syndrome resulting from various cardiac abnormalities.
  • It affects approximately 2% of the US population, representing a significant public health concern.
  • CHF impacts nearly every organ system, highlighting its systemic effects.

Purpose of the Study:

  • To review congestive heart failure (CHF) specifically due to left ventricular systolic dysfunction.
  • To explore the pathophysiology of CHF to inform new therapeutic strategies.
  • To evaluate current pharmacologic and non-pharmacologic treatment options.

Main Methods:

  • Review of existing literature on CHF pathophysiology and treatment.
  • Analysis of the benefits and drawbacks of various therapeutic interventions.

Related Experiment Videos

  • Focus on left ventricular systolic dysfunction as the primary cause.

    • Main Results:

    • Angiotensin converting enzyme (ACE) inhibitors have demonstrated improved survival rates in CHF patients.
    • Heart transplantation offers life-saving benefits for eligible individuals.
    • Current treatments, while effective, underscore the need for preventative measures.

    Conclusions:

    • Effective management of CHF requires a deep understanding of its underlying pathophysiology.
    • While treatments like ACE inhibitors and heart transplantation improve outcomes, preventing CHF is the ultimate goal.
    • Further research into early intervention and prevention strategies is crucial for combating CHF.